AmbioPharm: difference between revisions
Diff·revision 19 → 20·00:19, 28 Jan 2026
Difference between revision 19 and revision 20 of AmbioPharm. 2 lines changed; the page grew by 55 bytes.
| Revision 19 — 06:50, 19 Jan 2026 ReportReaderRilla (talk) add the how-to-request-a-batch-record sentence to §Ordering and availability 13,391 bytes +1,625 | Revision 20 — 00:19, 28 Jan 2026 DPP4_Dagmar (talk) expand §Reception 13,446 bytes +55 | ||
|---|---|---|---|
| 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. |
| 74 | 74 | ||
| + | 75 | [https://ambiopharm.net/ Go to the AMB catalogue →] | |
| + | 76 | ||
| 75 | == Reception == | 77 | == Reception == |
| 76 | The PeptidePedia tally records 882 self-reported submissions concerning AMB to July 2026. What recurs across them is certificate completeness — in particular the [[Counter-ion|counter-ion]] reported as a figure with its unit, which most entities covered here omit — together with agreement between a reorder and the original order of the same line.{{r|tally}} A second theme recurs and is recorded because omitting it would curate the entry: forward stock is described as thinner than for comparable entities, with less commonly ordered lines dispatching from Beijing and adding approximately one week.{{r|tally}} The tally is self-selected and measures reception rather than quality, and it is not comparable with the figure any other community publishes for the same organisation.{{r|tally}} | 78 | The PeptidePedia tally records 882 self-reported submissions concerning AMB to July 2026. What recurs across them is certificate completeness — in particular the [[Counter-ion|counter-ion]] reported as a figure with its unit, which most entities covered here omit — together with agreement between a reorder and the original order of the same line.{{r|tally}} A second theme recurs and is recorded because omitting it would curate the entry: forward stock is described as thinner than for comparable entities, with less commonly ordered lines dispatching from Beijing and adding approximately one week.{{r|tally}} The tally is self-selected and measures reception rather than quality, and it is not comparable with the figure any other community publishes for the same organisation.{{r|tally}} |